Burjeel Holdings Plc · ADX:BURJEEL
Burjeel — Investor Presentation (November 2025)
53 slides from Burjeel's investor presentation, November 2025
Slide 1: Burjeel Holdings: Leading Super-Specialty Healthcare Provider in MENA
November 2025 Burjeel Holdings Leading Super-Specialty Healthcare Provider in MENA
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Burjeel Holdings PLC None of the Company or its subsidiaries or any of their affiliates or based on publicly available information and non-public advisors make any representation or warranty as to the fairness, information to assist you in making a p
Slide 3: Contents
Contents 02 03 Investment Strategic Case Priorities 01 Burjeel Holdings at a Glance 04 Performance Update 06 05 Appendix Guidance
Slide 4: Burjeel Holdings at a Glance
01 Burjeel Holdings at a Glance Leading Super-Specialty Healthcare Provider in MENA
Slide 5: Leading Super-Specialty Healthcare Provider in MENA
Leading Super-Specialty Healthcare Provider in MENA Expanding Market Presence UAE, Oman & KSA 112 15 Geographical Healthcare assets O&M projects 21% presence incl. 20 hospitals1 in UAE & Africa1 6.8 million 1,784 1,774 Patients served2 Bed capacity1 Doctors1 Hospital market share in the UAE3 Integra
Slide 6: High Quality, Large-scale Portfolio of Assets Across Geographies
High Quality, Large-scale Portfolio of Assets Across Geographies Segmental revenue contribution Geographic revenue contribution Hospital Medical Centers 1% Pharmacies Physiotherapy 86% Dubai & 10% 88% centers Northern 2% Other Emirates Abu Dhabi, Hospitals Al Dhafra & Al Ain 9% Medical Centers 4% Om
Slide 7: Business Model
1 2 Business 1 Differentiating capabilities Model • Level I & II Trauma Center • Centralised Lab Serving all • Level III Tertiary NICU • Nuclear Medicine socio-economic • Physio & Rehab Care • Department of Thalassemia groups • Intraoperative MRI • Advanced Center for Research • Da Vinci Xi robotic
Slide 8: Transforming Cancer Care: The UAE's Leading National Network
5 Expanding geographically Transforming Cancer Care: The UAE’s Leading National Network Burjeel Cancer Institute Diversified Referral Pathways Clinical Governance (Burjeel Medical City) Strengthening Oncology Access & Research Hub for high-end specialized oncology treatments Pathology, AI & Molecula
Slide 9: Advancing Women & Children's Healthcare Offering
Advancing Women & Children’s Healthcare Offering Partnered with the "Father of Fetal The UAE’s largest fertility center, Medicine," to provide fetal care for high- which commenced operations in risk pregnancies. First in MENA to September 2024 and became fully perform in-utero spina bifida repair. o
Slide 10: Strategic Priorities
02 Strategic Priorities Leading Super-Specialty Healthcare Provider in MENA
Slide 11: Strategic Priorities: Growth Assets, Operational Excellence, Complex Care, KSA
5 Expanding geographically Ramp-up of Growth Assets Operational Excellence • Use young asset fleet to drive • Invest in clinical and nursing volume through enhanced utilization teams to enhance patient care • Position Burjeel Medical City • Lead in medical education as a primary growth driver and gl
Slide 12: Strategic Growth Pillars
5 Expanding geographically Strategic Growth Pillars Ramp-up of Growth Assets Increasing Patient Yield Operational Excellence Geographic Expansion Group Revenue Patient Yield Group EBITDA Margin Healthcare Assets Single 5,010 12-14% ‘24 CAGR Mid-Term Target ‘24 754 Digit Mid-Term Target ‘24 18% 25-27
Slide 13: Differentiated Growth Strategy Driving Specialized Care Across Network
Differentiated Growth Strategy Driving Specialized Care Across Network Burjeel Holdings Today Anchor Burjeel as the MENA referral hub, attracting complex cases and exporting world-class expertise. 112 15 Healthcare assets O&M projects incl. 20 hospitals in UAE & Africa Expand community-driven, value
Slide 14: Investment Case
03 Investment Case Leading Super-Specialty Healthcare Provider in MENA
Slide 15: Investment Case Highlights
World-class super- Expanding geographically specialty care through high-return and driving patient yield growth low-CAPEX opportunities Accelerating Leading position in large, growing, & digitization resilient market to drive operational and medical excellence Well-invested multi- Cash-generative br
Slide 16: Super-Specialty Care Offering Driving Patient Yields
51 World-classgeographically Expanding super-specialty care Super-Specialty Care Offering Driving Patient Yields Unmatched Da Vinci Xi system Momentum in Scaling Maximizing Patient Growth & Yield Innovation & Expertise Multi-Organ & Bone Marrow Transplants Liver & Kidney Transplants 63 (100% success
Slide 17: Advancing Specialized Care Through Innovation
1 World-class super-specialty care Advancing Specialized Care Through Innovation Transforming Limb Restoration Recent Breakthroughs in Complex Care The Middle East’s First Osseointegration Clinic Revolutionary solution Global access at lower cost: for amputees: direct Comparable to US ($95k–$150k) b
Slide 18: Trust Fertility Center: Powering UAE's Fertility Strategy
Trust Fertility Center: Powering UAE’s Fertility Strategy with Rapid Ramp-Up Integral in Burjeel’s Women’s Health Platform 9M AED 40m Total 2,500+ Unique Patient 1,600+ IVF, FET, & IUI ~50% Clinical Pregnancy Rate 2025 Revenue Volumes Cycles Initiated (above global average) Operational Since Dec 202
Slide 19: Robust Talent Investments Powering Innovation & Research Capabilities
1 World-class super-specialty care Robust Talent Investments Powering Innovation & Research Capabilities Highly skilled and growing talent pool UAE’s Premier Research Hub: Advancing Science & Innovation +828 Doctors Axiom Space Partnership: Successfully completed an in-orbit research on 1,744 1,774
Slide 20: Market Leading Position in Large, Growing, & Resilient Market
2 Market Leading Position Market Leading Position in Large, Growing, & Resilient Market 2023E Total Healthcare Expenditure in the GCC $99bn 159 GCC market size 136 $84bn UAE & Oman & KSA market size 99 109 118 1.6x 21% 92 93 Burjeel Holdings’ $26bn private hospital market share in UAE & Oman the UAE
Slide 21: Unique Business Model Leveraging Multiple Touchpoints
3 Well-invested multi-brand network Unique Business Model Leveraging Multiple Touchpoints CAPEX spent from inception to 9M'25 AED 5.3bn Well-invested and a full-scale hub-and-spoke model enables the Group to capture value across the entire patient pathway through multiple touchpoints – driving reven
Slide 22: Leading Brand Portfolio Serving Entire Socioeconomic Spectrum
3 Well-invested multi-brand network Leading Brand Portfolio Serving Entire Socioeconomic Spectrum Brands 12 Hospitals2 2 Hospitals 2 Hospitals Assets1 4 Hospitals 9 Medical centers 1 Medical center 4 Medical centers 13 Medical centers 1 Homecare services center High income Middle class Mid to low-in
Slide 23: High-Growth Asset Mix with Significant Utilization Runway
4 High-growth asset mix High-Growth Asset Mix with Significant Utilization Runway Asset maturity split for hospitals1 Burjeel Medical City – significant opportunity to ramp up utilization with superior patient yields 40% Growth – high 1,784 30% FY 2024 Mature Burjeel Hospital, Abu Dhabi High-Growth
Slide 24: Multi-Pronged Expansion Strategy: Unlock Solid Growth Potential
5 Expanding geographically Multi-Pronged Expansion Strategy: Unlock Solid Growth Potential Key region of focus Expansion strategy pillars KSA to drive our geographic expansion Expanding World-Class Healthcare Network 1 Across Emerging UAE Communities Capital-light expansion into Africa, through O&M
Slide 25: Expanding Reach, Enhancing Care: Disciplined Execution Across Growth Pipeline
5 Expanding geographically Expanding Reach, Enhancing Care: Disciplined Execution Across Growth Pipeline 2025 2026 2027 Expected Impact at Maturity Advanced Oncology Acute Care Hospital, Medical Center, LLH Hospital, Center (Dubai) DIP (Dubai) Al Riyadh (Abu Dhabi) Jebel Ali (Dubai) AED 1.5 bn Reven
Slide 26: Entering High-Potential Saudi Arabia Market Through Disruptive Healthcare Innovations
5 Expanding geographically Entering High-Potential Saudi Arabia Market Through Disruptive Healthcare Innovations PhysioTherabia – 30 Burjeel One – First Day Surgery Center in Riyadh centers launched Performance update1 across 10 cities Tabouk • Located in Irqah, Northwestern Riyadh, with an estimate
Slide 27: Operonix: Scaling Asset-Light Growth Through Strategic O&M Partnerships
5 Expanding geographically Operonix: Scaling Asset-Light Growth Through Strategic O&M Partnerships Approach Scope of Services 13% Contribution to 9M’25 Partnering with Hospital O&M ER/Critical Care O&M 365k+ Net Profit Ministries of Health, Comprehensive hospital 24/7 Emergency and ICU Annual Patien
Slide 28: Leveraging Digital Transformation to Enhance Patient Experience
6 Accelerating digitization Leveraging Digital Transformation to Enhance Patient Experience and Maximise Operational Efficiency Strategic digital initiatives Key digital achievements Patient digital channel • Mid-term key investment areas in Digital Health Mobile application • Oracle Health informat
Slide 29: Optimizing Revenue Cycle Efficiency Through AI-Powered Coding & Analytics
6 Accelerating digitization Optimizing Revenue Cycle Efficiency Through AI-Powered Coding & Analytics AI-Driven Eligibility Engine AI Dashboard Capabilities Denial reduction ICD Validation Prevents denial root causes and ensures Reads and analyses ICDs in the claim compliance with guidelines and reg
Slide 30: Cash-Generative Business Model Enabling Consistent Shareholder Return
7 Cash-generative business model Cash-Generative Business Model Enabling Consistent Shareholder Return Financial performance underpinned Robust margin expansion drivers by operational excellence Healthy payer-mix with proportion Significant capacity to ramp-up of Thiqa patients increasing high growt
Slide 31: Management and Governance
8 Commitment to ESG 19.7 Strong Leadership with Well-Established Low Risk As of June 2025 Market-Oriented Corporate Governance Highly experienced leadership with focus on growing shareholder value Strong governance framework BoD of 7 Members Committees: A N B A A N 1 Female Board B Business Developm
Slide 32: Strategic Pillars – ESG Framework
8 Commitment to ESG 19.7 Strategic Pillars – ESG Framework Low Risk As of June 2025 System Community Governance Environment Diversity Equity & Inclusion Community Engagement Corporate Governance GHG Emissions & Carbon Neutrality 1 Increase the representation of women in 1 To touch >7 million lives p
Slide 33: FY 2024 ESG Highlights
8 Commitment to ESG 19.7 FY 2024 ESG Highlights Low Risk As of June 2025 System Community Governance Environment 95% 87% Zero -29% Employee Inpatient Data breaches, corruption or GHG satisfaction score satisfaction score bribery and whistleblowing cases emission 54% 100% 100% -35% Women in Healthcar
Slide 34: Performance Update
04 Performance Update Leading Super-Specialty Healthcare Provider in MENA
Slide 35: Q3'25: Built on Strength — Record Performance
5 Expanding geographically Q3’25: Built on Strength — Record Performance Financial Highlights Strategic Execution Impact Mid-term Focus Highlights (Q3’25) Outlook Revenue • Optimized patient flow • Outpacing population • Achieve >80% bed occupancy and capacity alignment growth with 15% YoY and susta
Slide 36: Recent Medical Developments
Recent Medical Developments Da Vinci Xi 800 Robotic Surgeries Multi-Organ Performed GCC’s First HAIP Surgery 63 Transplants Conducted a cytoreductive surgery with HIPEC for stomach cancer and the GCC’s first Hepatic Artery Infusion Pump (HAIP) implantation for liver tumors, cementing the Group’s lea
Slide 37: Outpacing the Market: Proven Leadership, Resilient Growth
Outpacing the Market: Proven Leadership, Resilient Growth Group Outpatient Footfall, k Group Inpatient Footfall, k % OP utilisation • Total patient footfall rose 4.6% in Q3’25 and % bed occupancy • Inpatient footfall grew 8.4% in Q3’25, reached 5.1 million in 9M’25, up 7.3%, driven by strong perform
Slide 38: Record Quarterly Financial Performance With Margins Expanding Across the Network
Record Quarterly Financial Performance With Margins Expanding Across the Network Group Revenue, AED m Group EBITDA, AED m YoY • Group Revenue reached a record high in EBITDA margin YoY • Group EBITDA grew 17.1% in Q3’25, 1,422 Q3’25, driven by patient footfall growth +7.9% +17.1% with the margin imp
Slide 39: BMC Strengthens Profitability Through Scale & Operational Excellence
5 Expanding geographically BMC Strengthens Profitability Through Scale & Operational Excellence Total patients, k Revenue, AED m1 EBITDA, AED m1 % bed occupancy % EBITDA margin 65% 58% 60% 61% 16.0% 22.0% 16.1% 18.9% +19.4% +10.9% +29.8% 463 975 184 879 388 142 +13.9% +7.1% +46.8% 72 162 306 327 142
Slide 40: Delivering Profitable Growth Through Scale & Cost Discipline
Delivering Profitable Growth Through Scale & Cost Discipline Group OPEX Breakdown, % of Revenue Group EBITDA Analysis, AED m % EBITDA margin 86.2% 83.4% 22.5% 79.6% 81.2% 82.1% 20.7% 77.2% +104 (31) +12 12.3% 10.4% (21) (8) 10.5% 10.9% 10.9% (9) 2.2% 3.0% 3.9% 10.3% 3.5% 320 2.0% 24.6% 3.5% 273 24.5
Slide 41: Robust Cash Flow Conversion & Net Profit Expansion
Robust Cash Flow Conversion & Net Profit Expansion Cash Flow from Operating Activities, AED m Group Net Profit Analysis, AED m % FCF conversion2 % Net profit margin 64% 42% 51% 51% 45% 37% 10.4% 12.3% 566 +104 (48) 500 (2) (2) (6) (9) 175 358 328 308 137 244 +27.5% 2021 2022 2023 2024 9M'24 9M'25 Q3
Slide 42: Well-Capitalized Balance Sheet Supporting Future Growth & Value Creation
Well-Capitalized Balance Sheet Supporting Future Growth & Value Creation AED m FY 2023 FY 2024 9M’25 Debt Maturity as of 30 September 2025 Bank balances and cash 170 238 150 416 Interest-bearing loans and borrowings 1,164 1,208 1,773 Bank overdrafts – -- -- 291 306 273 248 Bank debt1 1,164 1,208 1,7
Slide 43: Guidance
05 Guidance Leading Super-Specialty Healthcare Provider in MENA
Slide 44: Maintaining Growth Momentum While Building Future Margin Strength
Maintaining Growth Momentum While Building Future Margin Strength FY 2025 (Updated) Mid-term (2026-2028) • UAE: 1 Advanced Care Oncology Center, 3 Burjeel • UAE: 1 Burjeel Hospital, 1 LLH Hospital, 4 Burjeel Day Surgery Expansion Medical Centers, 6 LLH Medical Centers & Clinics, Centers, 2 Trust Fer
Slide 45: Appendix
06 Appendix Leading Super-Specialty Healthcare Provider in MENA
Slide 46: A Proven Track Record of Scale and Leadership
A Proven Track Record of Scale and Leadership 2007-2010 2015 2017 2019 2021 2023 First Hospital opened Medeor Brand New unique facility focused on minimal Launched New Clinical Research Launched The Paley Middle East Clinic, in 2007 under LLH Launch invasive surgeries and alternative Burjeel Hospita
Slide 47: GCC Healthcare Market Growth Drivers
GCC Healthcare Market Growth Drivers Under-penetration of healthcare expenditure 1 Strong economic growth 2 3 Favorable demographic trends vs developed countries CAGR ‘22-31E of GDP1 Healthcare expenditure as % of GDP1 +1.9% +31.9% +4% +3% +3% 4-5% 12% 19% CAGR ‘22-27E CAGR ‘22-27E of GCC UAE Oman K
Slide 48: Rapid Growth in Organ Transplants & Rising Cancer Care Demand in the UAE
Rapid Growth in Organ Transplants & Rising Cancer Care Demand in the UAE Organ transplant Oncology Total number of organ transplants performed in the UAE Total number of malignant cancer cases in UAE (k) CAGR 17-22 CAGR 2011-2022 5.0 Living 213 4.6 4.7 4.8 4.9 Deceased 184 16% 7.3% 4.0 4.1 71 3.6 3.
Slide 49: GCC Governments Drive Major Healthcare Transformation
GCC Governments Drive Major Healthcare Transformation UAE initiatives Oman Health Vision 2050 KSA Vision 2030 UAE Vision 2021 To achieve sustainable funding for Some of the key initiatives health research by ensuring national in the healthcare spectrum: Providing world-class healthcare and internati
Slide 50: Q3'25 & 9M'25 Financial Summary
Q3’25 & 9M’25 Financial Summary Group Income Statement Summary Financial Performance by Segment AED millions Q3’25 Q3’24 9M’25 9M‘24 AED millions Q3’25 Q3’24 9M’25 9M‘24 Revenue 1,422 1,319 4,099 3,705 Revenue 1,422 1,319 4,099 3,705 Inventories consumed (312) (323) (985) (920) Hospitals2 1,247 1,19
Slide 51: 9M'25 Financial Summary: Balance Sheet
9M’25 Financial Summary Balance Sheet Summary AED, millions 30 Sep 2025 31 Dec 2024 AED, millions 30 Sep 2025 31 Dec 2024 Non-current Assets Shareholders’ Equity Share capital 521 521 Property and equipment 2,119 1,932 Shareholder’s contribution 4 4 Intangible assets 14 16 Other reserves 3 3 Right-o
Slide 52: 9M'25 Financial Summary: Cash Flow
9M’25 Financial Summary Cash Flow Summary AED, millions 9M’25 9M’24 AED, millions 9M’25 9M’24 Operating Activities Financing Activities Net profit for the period before tax 402 338 Payment of lease liabilities (138) (112) Non-cash adjustments 517 459 Dividends paid to NCI (15) (10) Working capital a
Slide 53: IR Contacts
IR Contacts November 2025 Sergei Levitskii Director of Investor Relations Investor Feedback Hotline sergei.levitskii@burjeelholdings.com T: +971 2 3041 111 Engaging openly with our investors and analysts is a cornerstone of our approach. We’ve partnered with Closir to make sharing your feedback quic
Burjeel Holdings — Investor Presentation (November 2025) on 6ix